...
机译:重新探测吡唑啉[3,4-D]嘧啶核苷作为抗锥体瘤Cruzi和抗腹癌药物
Univ Ghent Lab Med Chem Campus Heymans B-9000 Ghent Belgium;
Fundacao Oswaldo Cruz Inst Oswaldo Cruz FIOCRUZ Lab Biol Celular BR-21040360 Rio De Janeiro Brazil;
Fundacao Oswaldo Cruz Inst Oswaldo Cruz FIOCRUZ Lab Biol Celular BR-21040360 Rio De Janeiro Brazil;
Univ Perugia Dept Pharmaceut Sci I-06100 Perugia Italy;
Fundacao Oswaldo Cruz Inst Oswaldo Cruz FIOCRUZ Lab Biol Celular BR-21040360 Rio De Janeiro Brazil;
Univ Antwerp Lab Microbiol Parasitol &
Hyg LMPH B-2610 Antwerp Belgium;
Univ Ghent Lab Med Chem Campus Heymans B-9000 Ghent Belgium;
Univ Antwerp Lab Microbiol Parasitol &
Hyg LMPH B-2610 Antwerp Belgium;
Univ Ghent Lab Med Chem Campus Heymans B-9000 Ghent Belgium;
机译:吡唑并[3,4-D]嘧啶类碳环核苷的区域选择性合成作为可能的抗病毒剂
机译:无环吡唑并(3,4-d)嘧啶核苷可作为潜在的利什曼稳定剂。
机译:一种简单富有效的吡唑[3,4-B] [1,8]萘吡啶和吡唑啉[3,4-D]嘧啶[1,2-A]嘧啶衍生物作为抗炎剂
机译:一些吡唑基3,4-D嘧啶衍生物作为C-SRC抑制剂的QSAR研究
机译:嘌呤和嘧啶碳环核苷可作为抗病毒药。
机译:动能和e.p.r.尿嘧啶(1 H-吡唑并34-d嘧啶-46-二醇)抑制黄嘌呤氧化酶的研究。
机译:重新探测吡唑啉3,4d嘧啶核苷作为抗锥体瘤Cruzi和antileishmanialial
机译:芳香族非极性核苷作为嘧啶和嘌呤核苷的疏水等排物